J. Theodore Phillips and Elliot M. Frohman

Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis
Therapeutic Advances in Neurological Disorders 2008 1: 151-153. [PDF] [References] [Request Permission]  

Michael K. Racke and Olaf Stüve

Natalizumab: increased vigilance is required in treating patients with multiple sclerosis
Therapeutic Advances in Neurological Disorders 2008 1: 155-156. [PDF] [References] [Request Permission]  

Marinos C. Dalakas

Review: Therapeutic advances and future prospects in immune-mediated inflammatory myopathies
Therapeutic Advances in Neurological Disorders 2008 1: 157-166. [Abstract] [PDF] [References] [Request Permission]  

Dirk M. Hermann

Review: Future perspectives for brain pharmacotherapies: implications of drug transport processes at the blood—brain barrier
Therapeutic Advances in Neurological Disorders 2008 1: 167-179. [Abstract] [PDF] [References] [Request Permission]  

Peter Rieckmann, Anthony Traboulsee, Virginia Devonshire, and Joel Oger

Review: Escalating immunotherapy of multiple sclerosis
Therapeutic Advances in Neurological Disorders 2008 1: 181-192. [Abstract] [PDF] [References] [Request Permission]  

Claudia Bartels, Kira Späte, Henning Krampe, and Hannelore Ehrenreich

Review: Recombinant human erythropoietin: novel strategies for neuroprotective/neuroregenerative treatment of multiple sclerosis
Therapeutic Advances in Neurological Disorders 2008 1: 193-206. [Abstract] [PDF] [References] [Request Permission]  

Acknowledgements
Therapeutic Advances in Neurological Disorders 2008 1: 207. [PDF] [Request Permission]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.